SCHEMBL2316554

SCHEMBL2316554

NN=Cc1ccccc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 7/20 0.59
CA2 P00918 7/20 0.59
CA9 Q16790 6/20 0.59
KDM4E B2RXH2 2/20 0.59
SIRT2 Q8IXJ6 1/20 0.59
GAA P10253 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
CA1 P00915 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CTRC Q99895 1/20 0.52
DUSP3 P51452 1/20 0.52
PTPN5 P54829 1/20 0.52
PTPN11 Q06124 1/20 0.52
ALDH1A1 P00352 1/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
GFER P55789 1/20 0.52
PABPC1 P11940 1/20 0.50
APOBEC3A P31941 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19451062 1.00 CA12 (0.59) CA12CA2CA9KDM4ESIRT2
SCHEMBL29615332 1.00 CA12 (0.59) CA12CA2CA9KDM4ESIRT2
SCHEMBL2317419 1.00 CA12 (0.59) CA12CA2CA9KDM4ESIRT2
Alcohol SCHEMBL28211826 0.90 CA12 (0.55) CA12CA2CA9KDM4ESIRT2
SCHEMBL20338550 0.82 CA12 (0.51) CA12CA2CA9KDM4ESIRT2
SCHEMBL2316674 0.82 POLB (0.69) CA2KDM4ESIRT2GAAL3MBTL1
Sebacic Acid SCHEMBL27952310 0.81 CA12 (0.50) CA12CA2CA9KDM4ESIRT2
SCHEMBL28035152 0.81 CA12 (0.50) CA12CA2CA9KDM4ESIRT2
SCHEMBL5605340 0.80 RAB9A (0.67) CA12CA2CA9KDM4ESIRT2
SCHEMBL29735007 0.80 RAB9A (0.67) CA12CA2CA9KDM4ESIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110759833-B Preparation method and application of 4-hydroxy-benzyl (2' -hydroxy-benzylidene) -hydrazide 国家林业和草原局竹子研究开发中心 2022-06-14 CN claimed
CN-110759833-A Preparation method and application of 4-hydroxy-benzyl (2' -hydroxy-benzylidene) -hydrazide 国家林业和草原局竹子研究开发中心 2020-02-07 CN claimed
EP-1392219-A4 SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOTOSIS AND THE USE THEREOF CYTOVIA INC (US) 2007-01-24 EP claimed
US-20040186078-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2004-09-23 US claimed
US-6716859-B2 ANTICANCER AGENTS CYTOVIA, INC. 2004-04-06 US claimed
EP-1392219-A2 SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOTOSIS AND THE USE THEREOF Cytovia, Inc. (US) 2004-03-03 EP claimed
US-20030105140-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2003-06-05 US claimed
US-20030013743-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2003-01-16 US claimed
WO-2002102301-A2 SUBSTITUTED INDOLE-2-CARBOXYLIC ACID BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA, INC. (US) 2002-12-27 WO claimed
WO-2002089745-A2 SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA, INC. (US) 2002-11-14 WO claimed
US-20020128292-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2002-09-12 US claimed
EP-0661357-B1 Polymeric pigment dispersants for use in coating compositions BASF CORP (US) 2001-10-31 EP claimed
CN-115677554-B Aggregation-induced emission-based 3, 4-disulfide maleimide derivative fluorescent molecule, and preparation method and application thereof 巢湖学院 2025-03-18 CN disclosed
CN-115677554-A 3,4-dithioether maleimide derivative fluorescent molecule based on aggregation-induced emission, and preparation method and application thereof 巢湖学院 2023-02-03 CN disclosed
CN-113402417-B Zinc-aluminum ion recognition fluorescent probe and preparation method and application thereof 上海交通大学医学院附属瑞金医院 2023-01-03 CN disclosed
CN-115458164-A Prostate health index evaluation model and construction method and evaluation method thereof 上海微创惟微诊断技术有限公司 2022-12-09 CN disclosed
US-4767692-A NUCLEATING AGENT WITH UREA AND HYDRAZIDE GROUPS FUJI PHOTO FILM CO., LTD. (JP) 1988-08-30 US disclosed
US-4737452-A WITH AROMATIC COMPOUND CONTAINING MERCAPTO AND HYDROZIDE GROUPS FUJI PHOTO FILM CO., LTD. (JP) 1988-04-12 US disclosed
EP-0154293-A2 Silver halide photographic materials FUJI PHOTO FILM CO., LTD. (JP) 1985-09-11 EP disclosed
EP-0053098-A2 Alkanol-amine esters of cyclic 1,1'-biphenyl-2,2'-diyl and alkylidene-1,1'-biphenyl-2,2'-diyl phosphites CIBA-GEIGY AG (CH) 1982-06-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128292-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof BAD, API5, CASP2 CA12 584/4885CA2 123/4885CA9 704/4885
US-20030105140-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof BAD, API5, CASP2 CA12 584/4885CA2 123/4885CA9 704/4885
US-20040186078-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CASP2, CASP1, BCL2 CA12 3756/4885CA2 744/4885CA9 2544/4885
US-20030013743-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CASP2, CASP1, BCL2 CA12 3756/4885CA2 744/4885CA9 2544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.